The effect of various liposome formulations on insulin penetration across Caco-2 cell monolayer

被引:63
作者
Degim, Z [1 ]
Ünal, N
Essiz, D
Abbasoglu, U
机构
[1] Gazi Univ, Fac Pharm, Dept Pharmaceut Technol, TR-06330 Ankara, Turkey
[2] Food & Mouth Dis Inst, TR-06520 Ankara, Turkey
[3] Ankara Univ, Fac Vet, Dept Pharmacol & Toxicol, TR-06110 Ankara, Turkey
[4] Gazi Univ, Fac Pharm, Dept Microbiol, TR-06330 Ankara, Turkey
关键词
Caco-2; insulin; liposome; sodium taurocholate;
D O I
10.1016/j.lfs.2004.05.027
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The aim of the study was to determine the penetration properties of various insulin containing liposome formulations through Caco-2 cell monolayer and to compare the in vitro test results with in vivo tests. The effect of sodium taurocholate as a penetration enhancer when it was added to the liposome formulation was also investigated. In vitro permeation experiments were performed in diffusion cells with the Caco-2 cell monolayer used as the membrane. Permeability values of various insulin containing liposome formulations through Caco-2 cells were determined (log k(insulin-solution) = -2.217 +/- 0.0723 cm.h(-1), log k(insulin-liposome) = -2.141 +/- 0.0625 cm.h(-1), log k(insulin-sodium taurohalate liposome) = -1.952 +/- 0.0623 cm.h(-1)). In vivo tests were performed in mice. Formulations were administered orally and blood glucose levels were determined and penetrations were compared with the Caco-2 cell experiment results. In conclusion, the permeability of insulin was increased across Caco-2 cell monolayer when the liposome sodium taurocholate (NaTC) formulation was used. The oral administration of insulin and NaTC incorporated liposomes significantly decreased blood glucose levels. Furthermore, it was shown that a high in vitro/in vivo correlation was observed using the Caco-2 cell monolayer model. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:2819 / 2827
页数:9
相关论文
共 19 条
[1]  
ARTURSSON P, 1991, CRIT REV THER DRUG, V8, P305
[2]   Absorption and efficiency of insulin after oral administration of insulin-loaded nanocapsules in diabetic rats [J].
Cournarie, F ;
Auchere, D ;
Chevenne, D ;
Lacour, B ;
Seiller, M ;
Vauthier, C .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 242 (1-2) :325-328
[3]  
DEGIM T, 1998, 9 INT PHARM TECHN S, P79
[4]  
Degim Z., 2001, WORLD C PHARM PHARM, P53
[5]   Microparticulate uptake mechanisms of in-vitro cell culture models of the respiratory epithelium [J].
Foster, KA ;
Yazdanian, M ;
Audus, KL .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2001, 53 (01) :57-66
[6]   Human insulin diffusion profile through a layer of Caco-2 cells [J].
Greenwood, R ;
AlAchi, A .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1997, 23 (02) :221-224
[7]   DRUG-DELIVERY STUDIES IN CACO-2 MONOLAYERS .2. ABSORPTION ENHANCER EFFECTS OF LYSOPHOSPHATIDYLCHOLINES [J].
HOVGAARD, L ;
BRONDSTED, H ;
NIELSEN, HM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 114 (02) :141-149
[8]   Application of surface coated liposomes for oral delivery of peptide: Effects of coating the liposome's surface on the GI transit of insulin [J].
Iwanaga, K ;
Ono, S ;
Narioka, K ;
Kakemi, M ;
Morimoto, K ;
Yamashita, S ;
Namba, Y ;
Oku, N .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (02) :248-252
[9]   Mechanisms for absorption enhancement of inhaled insulin by sodium taurocholate [J].
Johansson, F ;
Hjertberg, E ;
Eirefelt, S ;
Tronde, A ;
Bengtsson, UH .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 17 (1-2) :63-71
[10]  
KIM B, 2003, INT J PHARM